These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 11392579)
1. Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function. Barnes N; Wei LX; Reiss TF; Leff JA; Shingo S; Yu C; Edelman JM Respir Med; 2001 May; 95(5):379-86. PubMed ID: 11392579 [TBL] [Abstract][Full Text] [Related]
2. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%. Becker A; Swern A; Tozzi CA; Yu Q; Reiss T; Knorr B Curr Med Res Opin; 2004 Oct; 20(10):1651-9. PubMed ID: 15462699 [TBL] [Abstract][Full Text] [Related]
3. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of montelukast in the treatment of cough variant asthma. Spector SL; Tan RA Ann Allergy Asthma Immunol; 2004 Sep; 93(3):232-6. PubMed ID: 15478381 [TBL] [Abstract][Full Text] [Related]
5. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma. Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601 [TBL] [Abstract][Full Text] [Related]
6. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study. Ilowite J; Webb R; Friedman B; Kerwin E; Bird SR; Hustad CM; Edelman JM Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991 [TBL] [Abstract][Full Text] [Related]
9. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial. Zeiger RS; Bird SR; Kaplan MS; Schatz M; Pearlman DS; Orav EJ; Hustad CM; Edelman JM Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697 [TBL] [Abstract][Full Text] [Related]
10. Effect of montelukast on peripheral airflow obstruction in children with asthma. Spahn JD; Covar RA; Jain N; Gleason M; Shimamoto R; Szefler SJ; Gelfand EW Ann Allergy Asthma Immunol; 2006 Apr; 96(4):541-9. PubMed ID: 16680924 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity. Busse WW; Casale TB; Dykewicz MS; Meltzer EO; Bird SR; Hustad CM; Grant E; Zeldin RK; Edelman JM Ann Allergy Asthma Immunol; 2006 Jan; 96(1):60-8. PubMed ID: 16440534 [TBL] [Abstract][Full Text] [Related]
12. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma. Lu S; Liu N; Dass SB; Reiss TF J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166 [TBL] [Abstract][Full Text] [Related]
13. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children. Raissy HH; Harkins M; Kelly F; Kelly HW Pharmacotherapy; 2008 Mar; 28(3):287-94. PubMed ID: 18294107 [TBL] [Abstract][Full Text] [Related]
14. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study. Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R; Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886 [TBL] [Abstract][Full Text] [Related]
15. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Garcia Garcia ML; Wahn U; Gilles L; Swern A; Tozzi CA; Polos P Pediatrics; 2005 Aug; 116(2):360-9. PubMed ID: 16061590 [TBL] [Abstract][Full Text] [Related]
16. Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years. Nelson KA; Smith SR; Trinkaus K; Jaffe DM Pediatr Emerg Care; 2008 Jan; 24(1):21-7. PubMed ID: 18165796 [TBL] [Abstract][Full Text] [Related]
17. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity. Papadopoulos NG; Philip G; Giezek H; Watkins M; Smugar SS; Polos PG J Asthma; 2009 May; 46(4):413-20. PubMed ID: 19484680 [TBL] [Abstract][Full Text] [Related]
19. Review of recent results of montelukast use as a monotherapy in children with mild asthma. Wahn U; Dass SB Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477 [TBL] [Abstract][Full Text] [Related]
20. A clinical trial of the efficacy and safety of montelukast as monotherapy in patients with chronic stable bronchial asthma. Athavale A; Souza GA; Avasthi R; Singh NP; Kale M; Taneja A; Sireesha K J Indian Med Assoc; 2004 Feb; 102(2):109-11. PubMed ID: 15200214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]